The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults

J. Michael Kilby, Jacob P. Lalezari, Joseph J. Eron, Margrit Carlson, Calvin Cohen, Roberto C. Arduino, Jeffrey C. Goodgame, Joel E. Gallant, Paul Volberding, Robert L. Murphy, Fred Valentine, Michael S. Saag, Emily L. Nelson, Prakash R. Sista, Alex Dusek

Research output: Contribution to journalArticlepeer-review

188 Scopus citations

Fingerprint

Dive into the research topics of 'The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science